Source: Virtual Congress 2021 – Therapy of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
A. Casal (Santiago de Compostela, Spain), M. Torres (vigo, Spain), I. Parente (Orense, Spain), A. Golpe (Santiago de Compostela, Spain), C. Montero (A Coruña, Spain), V. Leiro (Vigo, Spain), O. Castro (Lugo, Spain), A. Fernández (Vigo, Spain), L. Valdés (Santiago de Compostela, Spain), A. Ruano (Santiago de Compostela, Spain). Genetic polymorphisms in the BER and NER pathways and their influence on survival and toxicity in never-smokers with lung cancer. 2300

Member's Comments

No comment yet.

Related content which might interest you: Combined effect of p53 and XRCC1 gene polymorphisms on age-associated lung cancer risk Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics Year: 2008 Polymorphisms in telomere maintenance genes and risk of lung cancer Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 Genotyping single-nucleotide polymorphisms (SNP) in ERCC1, XPD, XRCC1, XRCC3 and MDR-1 and CCND-1 genes for response and toxicity prediction in chemotherapy of non small cell lung cancer (NSCLC) Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Analysis of XPD gene Lys751Gln polymorphism as predisposing factor for non-small cell lung cancer (NSCLC) development Source: Eur Respir J 2007; 30: Suppl. 51, 131s Year: 2007 Polymorphisms in cancer-related pathway genes and lung cancer Source: Eur Respir J 2016; 48: 1184-1191 Year: 2016 TP53 Arg72Pro, GSTM1, GSTP1 Ile105Val and GSTT1 gene polymorphisms as predisposing factors for non-small cell lung cancer (NSCLC) development Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer Year: 2006 Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005 Influence of common p53 and XRCC1 variant alleles on risk of lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 Arg72Pro and GSTM1 gene polymorphisms increase the risk of non small cell lung cancer (NSCLC) Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005 Association of XPD and CDA polymorphisms with clinical outcome in non-small cell lung cancer in a Chinese population Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Association of DNA repair gene XRCC7 G6721T polymorphisms withnon-small cell Lung cancer Source: International Congress 2019 – Epidemiology, genetics, air pollution and sleep Year: 2019 Role of genome integrity genes polymorphism in risk of lung cancer of middle-aged men Source: Eur Respir J 2007; 30: Suppl. 51, 132s Year: 2007 The effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 Arg72Pro P53 gene polymorphism as a predisposing factor for non-small cell lung cancer (NSCLC) development Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 DNA methylation mediates the association between occupational exposures and lung function Source: International Congress 2017 – Epigenetics of lung function Year: 2017 DNA methylation is associated with lung function levels in never-smokers Source: International Congress 2017 – Epigenetics of lung function Year: 2017 Shared epithelial pathways to lung repair and disease Source: Eur Respir Rev, 26 (144) 170048; 10.1183/16000617.0048-2017 Year: 2017 Polymorphisms A1026G and G369C of CDKN1A/p21 and p53 genes in lung cancer Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011